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The complex structure of bacteriophage T4 includes a variety of proteins' which
become assembled into mature particles during intracellular development of the
virus. Some insight into the genetic control of this process has been provided by
physiological studies with conditional lethal mutants, which show that over 40
phage genes are involved in T4 morphogenesis2 (Fig. 1). However, the mechanisms
by which components are assembled have remained obscure, due in part to the
lack of a suitable system for their study. In the experiments reported below, con-
ditional lethal mutants of strain T4D have been exploited to develop an in vitro
system in which several of the steps in phage morphogenesis can be demonstrated.
Methods and Materials.-Incubations and growth of liquid cultures were carried out at 30'C
unless otherwise indicated. Previously described procedures were employed for preparation and
assay of phage stocks, and for complementation tests between amber (am) mutants.2
Phage strains: All strains are derivatives of T4D unless otherwise indicated. Wild type, the
rI mutant r48, and most of the am mutants employed have been described previously.2 Am
mutants of phage T2L were isolated and characterized by R. L. Russell. Mutations carried by
the T2 am strains were assigned to homologous T4 genes on the basis of T2 am X T4 am com-
plementation tests. Additional information on the phenotypic defects of the various mutants is
given in Figure 1 and the tables.
Escherichia coli host strains were employed as follows: CR 63 (permissive for am mutants) for
all phage assays and preparation of stocks; B/5 (nonpermissive) for preparation of infected cell
extracts; S/6 (nonpermissive) as a selective plating indicator for am+ phage; B/2, S/4 (resistant
to adsorption of T2 and T4, respectively) for adsorption experiments (see Table 1).
Media and reagents: H broth, used for growth of bacteria, and EHA top and bottom agar,
used for plating assays, were prepared as described previously.' Buffer contained Na2HPO4
(0.039 M), KH2PO4 (0.022 M), NaCl (0.07 M), and MgSO4 (0.01 M) at pH 7.4. Crystalline
bovine pancreatic DNase was obtained from Sigma Chemical Co.
Tail-fiberless particles were prepared using a multiple am mutant (X4E) defective in the tail-
fiber genes 34, 35, 37, and 38 (am mutations: B25, A455, B252, N52, B280, and B262). A culture
of coli B/5 was grown to 4 X 108 cells/ml, infected with X4E phage at a multiplicity (m.o.i.) of
4, aerated for 3 hr, and then treated with CHCl3 to lyse the infected cells. The defective particles
were purified by two cycles of low- and high-speed centrifugation and suspended in buffer. The
particle concentration was estimated from the optical density of the suspension at 265 miu, as-
suming OD265 = 1.0 for a suspension of 1.2 X 1011 particles/ml.4 Fewer than 0.01% of the par-
ticles in such preparations formed plaques when plated on CR 63 indicator bacteria.
Infected-cell extracts: A culture of B/5 was grown in H broth at 37°C to 4 X 108 cells/ml,
cooled to 30°C, infected (0 min) at m.o.i -4 with phage of the desired genotype, and aerated
vigorously at 30°C. Assays of surviving bacteria were generally made to verify that most of the
cells were infected. At 30 min the culture was rapidly chilled by pouring into large iced Erlen-
meyer flasks. (Following infection with wild-type T4D at 30'C, intracellular phage first appear
at 23 min and spontaneous cell lysis does not begin until about 40 min.) The chilled culture was
concentrated about 200 times by centrifugation at 5000 X g for 8 min and resuspension of the
viscous pellet in buffer containing DNase (10 pg/ml). Microscope counts indicated 10-20%
recovery of intact cells. (The low recovery is probably due to the fragility of the cells at this
stage of the latent period.) The resuspended pellet was frozen at -70°C in a dry ice-ethanol
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bath, thawed at 30'C, and either used immediately or refrozen at -70'C and stored at -20'C.
(Extracts retain considerable activity upon storage of up to 1 month.) As determined by micro-
scope count, this procedure disrupted 99% of the cells. Protein content of the extracts, estimated
colorimetrically,5 varied between 20 and 30 mg/ml. Infectious phage were present at levels of
108 to 3 X 1010 per ml, due to unadsorbed phage and the low but finite transmission ofam mutants.
Extracts are referred to in the text by the number of the defective gene of the am mutant used
to infect the cells.
Results.-Activation of tail-fiberless particles: Since gene 23 controls the syn-
thesis of the major structural component of the head membrane,6 a 23-extract
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FIG. 1.-Defective phenotypes of conditional lethal mutants of T4D under restrictive conditions.
Characterized genes are represented by shaded areas illustrating relative locations and, if known,
approximate map lengths.
The enclosed symbols indicate defective phenotypes as follows: DNA NEG., no DNA synthesis;
DNA ARREST, DNA synthesis arrested after a short time; DNA DELAY, DNA synthesis com-
mences after some delay; MAT DEF., maturation defective, DNA synthesis is normal but late
functions are not expressed; a hexagon indicates that free heads are produced, an inverted T, that
free tails are produced; TAIL FIBER, fiberless particles produced; gene 9 mutants produce in-
active particles with contracted sheaths; gene 11 and 12 mutants produce fragile particles which
dissociate to free heads and free tails. Based on previously published2 and unpublished experi-
ments.2' -''
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tive phage/ml of reaction mixture. cal density (see Methods and Materials).
(prepared from nonpermissive cells infected with am B17, a T4D mutant de-
fective in gene 23) should contain all of the components required for tail-fiber
assembly but no phage heads or complete particles. When purified tail-fiberless
particles (see Methods and Materials) are incubated with 23-extract, the titer of
active phage in the mixture rapidly increases over 3 orders of magnitude to a level
approaching that of the fiberless particles initially added (Fig. 2). The kinetics of
active phage production are not linear. No increase in active titer is observed upon
incubation of either the extract or the fiberless particles alone.
As shown in Figure 3, the number of active phage produced is proportional to the
number of fiberless particles added to the mixture. Within the error of measure-
TABLE 1
ADSORPTION AND SEROLOGICAL SPECIFICITIES OF ACTIVATED PHAGE
Fraction Unadsorbed to: Fraction surviving
Phages B/5 B/2 S/4 anti-T4 serum
T4r48 0.002 0.01 0.8 0.01
T2L 0.001 0.9 0.00 0.43
X4E-4 0.004 0.003 1.00 0.01
X4E-4P 0.06 0.1 0.7 0.01
X4E-2 0.001 0.9 0.2 0.13
X4E-2P 0.1 0.2 1.2 0.01
Phages: T4r48: T4 control; T2L: T2 control; X4E-4: fiberless T4 particles activated by 23-ex-
tract; X4E-4P: progeny of X4E-4; X4E-2: fiberless T4 particles activated by T2 am 108 (gene 20)
extract; X4E-2P: progeny of X4E-2.
Adsorption experiments: Phage were mixed with suspensions of the indicated bacteria (4 X 108/ml)
in H broth containing 0.004 M KCN. After 15 min, incubation samples were shaken with CHCI-satu-
rated broth and assayed to determine the fraction of input phage remaining unadsorbed.
Inactivation by antiserum: Hyperimmune anti-T4 rabbit serum was used at a dilution giving 1%
survival of T4D phage in H broth after 8 min at 30 C.
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ment, activation is quantitative when the incubation period is extended to 200
min, and no further increase in active titer is observed beyond this point. Lower-
ing the concentration of 23-extract by a factor of 2 decreases the rate of the reac-
tion, but not the final yield of active phage. No reaction is observed at 00C.
The following experiments provide evidence that activation reflects the attach-
ment of tail-fiber components present in the extract to the fiberless phage particles.
(1) Complementation spot tests were used to determine the genotype of 40 of the
phage particles activated in two separate experiments. All 40 were of genotype
X4E, that of the fiberless particles added.
(2) An extract of cells infected with a T2L mutant (am 108) defective in gene 20
(required for head membrane formation) was found to activate fiberless T4D
particles as described above. The progeny of particles activated in the presence of
this extract and of particles activated with a T4D 23-extract were obtained by
growth for one cycle on strain CR 63. Samples of the T2 extract-activated and
T4D extract-activated phage and their progenies were then compared with T2L
wild type and T4D r48 for adsorption to B, B/2, and S/4 bacteria, and for neu-
tralization by anti-T4 serum (Table 1). Phage activated with the T2 extract
showed the adsorption characteristics, and, to some extent at least, the serological
properties of T2L. Their progeny, however, behaved like the T4D extract-acti-
vated phage and the T4D control samples. These results support the view that
activated phage are T4D particles with either
T2 or T4D tail fibers, depending upon the ex-
tract used in the activation reaction. 0S2MPLE
(3) As a more direct test for attachment of 0
fibers, samples of phage from the reaction mix- '°f
ture of Figure 2 were removed after 0, 12, and 5 f
200 min of incubation and photographed in the _ _ _
electron microscope by Dr. Ni. Moody, after 12min SAMPLE
purification by three cycles of high- and low- 5 -
speed centrifugation and negative staining with U 0-*
uranyl acetate. The fractions of active par- ,
ticles in the three samples were, respectively, f
0.1, 10, and 100 per cent. Counts of the num- °.120mi SAMPLE
ber of fibers per particle in the three samples i5-g2.9
(Fig. 4) indicate that the phage acquire tail 10
fibers during incubation with the extract. The
results suggest that more than one fiber is 5-l
necessary for activity, since over 70 per cent of 0 2* 4 5 6
the particles in the 12-min sample show one or FIBERS PER PARTICLE
more fibers, whereas only 10 per cent are able to FIG. 4.-Tail-fiber counts from elec-tron micrographs of extract-activatedform plaques on CR 63. phage tsee text). Counts were made on
Extract complementation among tail-fiber mu- two.or more fields from each sample,
scoring only particles with clearly vis-tants: Mutants defective in one or more of ible end plates on an unobstructed
the genes 34, 35, 36, 37, 38, and 57 fail to background. For each time point the
average number of visible fibers perproduce active progeny under restrictive con- phage (m-) is given. It should be noted
ditions in vivo. They do, however, produce a that six fibers per phage are seldomvisible even in preparations of wild-
normal yield of nonnfectious phage particles type T4D.
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which lack tail fibers.2 Antigenic studies with am mutants indicate that genes
34, 36, and the gene pair 37-38 control the synthesis of three antigens, designated
A, B, and C, respectively, which are found in wild-type T4 lysates associated with
the tail fibers of active phage.7 Under restrictive conditions, gene 57 mutants pro-
duce low levels, and gene 35 mutants give normal levels of all three antigens.
However, the inactive particles produced by all of the above tail-fiber mutants are
devoid of associated antigens (J. King, unpublished).
The preceding experiments indicate that fiber attachment to fiberless particles
can proceed in vitro. By mixing extracts made with mutants defective in different
tail-fiber genes, some of the earlier steps in fiber assembly can be shown to occur as
well. We shall refer to the production of active phage under these conditions as
"extract complementation."
No increase in active phage titer is observed upon incubation of 34, 35, 36, 37, or
38 extracts alone or with added fiberless particles. However, when pairwise com-
binations of extracts are allowed to react, the fiberless particles present in the ex-
tracts become activated in some, but not all, of the mixtures (Table 2). Of par-
ticular interest are combinations such as 34 + 36 and 34 + 37. Since each of the
extracts lacks one of the three antigens, the observed activity suggests that at least
two steps occur in the mixture: association of the antigens and their attachment to
the phage. The partial or complete inactivity of all pairwise combinations among
36, 37, and 38 indicates that not all of the reactions in fiber assembly proceed ef-
ficiently in the in vitro system as presently constituted. (The results of tests with
TABLE 2
EXTRACT COMPLEMENTATION AMONG PAIRS OF TAIL FIBER MUTANTS
Tail-fiber
antigens present: A, B, C B, C A, B, C A, C A A
Defective gene no. 23* 34 35 36 37 38
38 1000 370 187 9.4 2.6 2.6
37 269 38 65 2.6 2.2
36 268 238 70 0.4
35 1050 55 3.3
34 835 2.8
23* 0.8
Equal volumes of two extracts were mixed, incubated 90 min, and then assayed for plaque-forming phage.
Results are expressed as titer (active phage/ml) X 10-9 in the reaction mixture. Numbers at the bottom
of each column represent active titers observed after 90 min incubation of each extract alone. Am mutants
employed for extract preparation were as follows: 38, am C290; 37, X2j (double mutant: am N52 and
am B280); 36, am El; 35, am B252; 34, X2d (double mutant: am B25 and am A455); 23, am B17.
The first column heading gives the antigenic components found in defective lysates of the mutants listed in
the second column heading.
* Control; defective in head formation.
TABLE 3
EXTRACT COMPLEMENTATION BETWEEN HEAD AND TAIL MUTANTS
Defective
gene number 5 6 10 27 29 2 23 31
31 - 91 20 21 1.0 2.3 0.8
23 283 180 176 445 278 3.7 3.8
2 189 218 137 352 132 5.3
29 1.5 1.8 0.9 9.9 3.5
27 1.4 1.5 0.7 0.7
10 1.6 2.2 0.4
6 2.6 3.4
5 2.7
Pairwise mixtures of extracts were allowed to react, and the results are expressed as in Table 2, except
that incubation time was increased to 120 min. The am mutants employed are given in Table 5.
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TABLE 4
FUNCTIONAL PROPERTIES OF MORPHOGENETIC-MUTANT EXTRACTS
_-- Extract -_ _ Incubated with --Mutant Phenotype--
Defective Am 23-Extract 6-Extract Functional Components
gene mutant Self (tail donor) (head donor) components visible in EM
2 N51 5.3 3.7 218 T HT
64 E1102 1.8 8.9 205 T HT
50 A458 20 23 229 T HT
65 E348 5.2 9.5 133 T HT
4 N112 36 80 407 T HT
53 H28 1.4 181 1.6 H H
5 N135 2.7 283 2.6 H H
6 N102 3.4 180 H H
7 B16 1.2 263 1.6 H H
8 N132 1.3 518 3.5 H H
9 E17 7.8 76 458 HT Co
10 B255 0.38 176 2.2 H H
11 N93 3.8 15 14 HT OHT
12 N69 0.9 104 261 HT OHT
13 E609 0.5 636 216 HT HT
14 B20 1.1 337 426 HT HT
15 N133 5.6 936 923 HT HT
16 N66 1.7 1.8 149 T HT
17 N56 0.5 0.5 96 T HT
18 E18 0.3 447 775 HT HT
20 N50 0.4 1.6 57 T T
21 N90 20 8.9 165 T T
22 B270 2.6 1.1 141 T T
23 B17 0.83 180 T T
24 N65 0.7 0.8 135 T T
25 N67 29 608 16 H H
26 N131 4.1 144 3.6 H H
51 S29 1.6 67 1.8 H H
27 N120 0.7 1670 1.5 H H
28 A452 3.0 91 2.3 H H
29 B7 3.5 278 1.8 H H
48 N85 0.7 107 1.6 H H
54 H21 0.9 137 6.4 H H
31 N54 0.8 0.9 350 T T
49 E727 1.3 1.4 125 T HT
Extracts are listed in the map order of the corresponding defective genes (see Fig. 1). Incubations were
carried out and the results are expressed as in Table 3. Interpretation of the results is given under the head-
ing "Functional components." Extracts complementing 6-extract (reference head donor) but not 23-extract(reference tail donor) to produce active phage are designated as tail donors (T); those complementing 23
but not 6 as head donors (H), and those complementing both reference extracts as both head and tail donors(HT). The last column lists for comparison the previously determined defective phenotypes of the various
mutants.2 The symbols indicate the presence of free heads (H), free tails (T), complete particles (4), and
particles with contracted sheaths (C4s) in electron micrographs of defective lysates.
57-extracts, not shown, were ambiguous due to the high leakage of gene 57 mutants.)
Genotype tests of phage produced in the active combinations show that endog-
enous particles from either extract can be activated by tail-fiber attachment.
Assays of the activated phage on the restrictive host S/6 revealed no am+ recom-
binants, a further indication that the increase in active titer is due to an extracel-
lular process. If the observed complementation were due to mixed infection by
the two mutant phages of uninfected cells present in the extracts, then the re-
sulting progeny would be expected to include 5-35 per cent am+ recombinants, de-
pending upon the map interval between the two defective genes employed.
Extract complementation among other morphogenetic mutants: The experiments
described above indicate that the attachment of tail fibers to fiberless particles and at
least some of the steps in fiber assembly can proceed in extracts with high efficiency.
To test the in vitro efficiency of other steps in the maturation process, extracts
were prepared from cells infected with a number of mutants defective in various
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morphogenetic genes. These were examined in pairs for extract complementation
as above (Table 3). Platings on the restrictive host S/6 indicated that < 10-3
am+ recombinants were generated in the many mixtures tested. In most cases the
results of the test were unambiguous, either showing no increase over the controls
(no complementation) or more than a tenfold increase (complementation).
A striking correlation is found between the extract complementation behavior of
mutants and their defective phenotypes.2 Mutants which produce heads but no
tails as determined in the electron microscope (EM), and thus presumably are
blocked in tail assembly, do not complement among themselves (genes 5, 6, 10, 27,
29) but do complement with mutants which produce tails, but no heads (genes 23,
31). Many other tests not shown in Tables 3 or 4 support this generalization.
These results suggest that the attachment of heads to tails can proceed in vitro, and
that mutant extracts can be classed as "head donors" or "tail donors," extracts from
one class being active only with extracts from the other.
To test this generalization further, infected-cell extracts were prepared using am
mutants defective in each of 35 genes known to be involved in morpho-
genetic steps other than tail-fiber assembly.2 (Genes identified only with tempera-
ture-sensitive mutants were not tested.) Each extract was tested for activity
against a reference head donor (6-extract) and a reference tail donor (23-extract).
As shown in Table 4, every mutant showing the EM phenotype of heads but no
tails behaves as a head donor only (14 tested), while every mutant showing tails but
no heads behaves as a tail donor only (6 tested). Most of the class of mutants pro-
ducing both heads and tails (unattached; see Flig. 1) also behave as tail donors only
(8/12). Apparently the heads observed by EM are either incomplete or nonfunc-
tional by-products of defective maturation which cannot be efficiently activated in
extract mixtures. However, extracts made with the remaining four mutants of this
class (genes 13, 14, 15, and 18) behave as both head and tail donors, suggesting that
they contain functionally competent heads and tails but lack components required
for their union. These preparations, in contrast to those of head donors only and
tail donors only, also complement extracts made with double mutants which produce
neither heads nor tails (one defective in genes 10 and 31, another in genes 27 and 23).
Mutants defective in genes 9, 11, or 12 also show extract complementation with
both the reference head donor and the reference tail donor, as well as with the double
mutants. Under restrictive conditions in vivo, 9, 11, and 12 mutants produce ap-
parently complete but inactive phage particles characterized in the electron micro-
scope by contracted sheaths (gene 9 mutants) or a tendency to dissociate into free
TABLE 5
GENOTYPES OF EXTRACT-ACTIVATED PHAGE; HEAD AND TAIL MUTANTS
-E xtractA - _ ExtractB . -Number of Phage-
Gene Functional Gene Functional Genotype Genotype
defect components defect components A B
29 H 23 T 20 0
14 HT 23 T 20 0
14 HT 6 H 11 9
6 H 2 T 20 0
14 HT 2 T 20 0
14 HT 16 T 20 0
6 H 16 T 20 0
Genotypes of the phage particles activated during 120-min incubation of the indicated extract mixtures
were determined by spot testing for complementatiQu with appropriate known mutant strains.
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heads and tails upon storage (gene 11 and 12 mutants). The extract complementa-
tion results suggest that these defective particles can be activated when a missing
component is provided by another extract.
Complementation spot tests of phage produced in the active combinations of
Tables 3 and 4 show that their genotype is exclusively that of the head donor
(Table 5). When 14-extract, a head and tail donor, complements a tail donor ex-
tract, the phage produced are of genotype 14; when it complements a head donor
extract, comparable numbers of the two genotypes are found among the active
particles.
Discussion and Summary.-The results reported here show that several of the
steps in the morphogenesis of bacteriophage T4D can take place in extracts of in-
fected cells. These steps include the assembly of tail fibers and their attachment to
the virus particle, as well as the union of the head and the tail. Apparently many
of the larger components-fiberless particles, fibers, heads, and tails-which ac-
cumulate in mutant-infected cells under restrictive conditions are not aberrant by-
products of defective synthesis, but intermediates in the assembly process which
may be utilized in vitro for the morphogenesis of active virus.
The limited success of our attempts at complementation in extracts indicates that
many of the steps in the maturation process do not proceed efficiently under the
conditions presently employed. It remains to be seen whether some of these steps,
such as the formation of the head or of the tail, can be demonstrated under altered
conditions, for example, at higher concentration of reactants.
As an extension of the previously reported EM characterization of defective
phenotypes,2 the extract complementation studies provide some further insight into
the functions controlled by the various mutationally defined morphogenetic genes.
An example is the group of 12 genes whose mutants produce unattached heads
and tails recognizable in electron micrographs. While four of these are apparently
involved in the union of heads and tails, the remaining eight may be required to
complete or alter the head in some manner which activates it for tail attachment.
Perhaps most significantly, our results show that at least portions of the morpho-
genetic pathway are open to direct attack by biochemical methods. It may be
hoped that purification of components and further study of individual reactions
will lead to some understanding of the interactions and specificities involved in the
assembly of complex supramolecular structures such as bacteriophage T4.
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